Performance of Contrast-Enhanced Spectral Mammography to Assess Neoadjuvant Chemotherapy Response (CEDM)

NCT04625517 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Low enrollment

Conditions

Breast Cancer

Interventions

PROCEDURE: Digital Mammography
DRUG: Low Osmolar Contrast Material, 300-399 Mg/Ml Iodine Concentration, Per Ml

Sponsor

University of Texas Southwestern Medical Center